Our Sites
With China headquarters and R&D China center located in Shanghai, we have established global supply sites in Wuxi, Taizhou, and Qingdao providing high quality medicines to over 70 global markets. In recent years, we have also established regional headquarters in Beijing, Guangzhou, Hangzhou, Chengdu and Qingdao. Joining hands with partners, we have built a diversified international healthcare innovation ecosystem driven by China Commercial Innovation Center (CCiC), International Life Science Innovation Campus (iCampus) and AstraZeneca-CICC Healthcare Industrial Fund to stimulate regional economic vitality and healthcare industry growth.
This means that regardless of your role within the diverse functions that AstraZeneca offers, you will have the opportunity to explore a wide range of possibilities across China. You have the opportunity to drive industry-leading innovation by collaborating with top experts both internally and externally. Through a multi-dimensional approach, we aim to benefit patients worldwide – in China, for Global.